Heparins as cancer therapy: in theory, they should have worked

Lancet Haematol. 2020 Oct;7(10):e703-e704. doi: 10.1016/S2352-3026(20)30276-3.

Authors

Florian Posch¹, Stefan Hatzl², Cihan Ay³

Affiliations

¹ Division of Oncology, Department of Internal Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Electronic address: florian.posch@medunigraz.at.
² Division of Haematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
³ Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Comprehensive Cancer Centre Vienna, Vienna, Austria.

PMID: 32976743
DOI: 10.1016/S2352-3026(20)30276-3

No abstract available

Publication types

Comment

MeSH terms

Heparin*
Heparin, Low-Molecular-Weight
Humans
Neoplasms*

Substances

Heparin, Low-Molecular-Weight
Heparin